|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Etanercept (Enbrel) in patients with rheumatoid arthritis with recent onset versus established disease:improvement in disability显示文摘 | Baumgartner SW Fleischmann RM Moreland LW | 2004 | J Rheumatol2004，31，： | 1 |
| 2 | A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis显示文摘 | Bathon JM Martin RW Fleischmann RM | 2000 | N Engl J Med2000，343，22： | 1 |
| 3 | Long- term (52-week) results of a phase 3, randomized, controlled trial of apremilast, an oral phosphodiesterase 4 inhibitor, in patients with psoriatic arthritis (PALACE 2)显示文摘 | CUTOLO M MYERSON GE FLEISCHMANN RM | 2013 | Arthritis Rheum2013，65，10： | 1 |
| 4 | Adalimumab,a fully human anti-tumor necrosis factor-alpha monoclonal antibody,and concomitant standard anti-rheumatic therapy for the treatment of rheumatoid arthritis :results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis )显示文摘 | Schiff MH Fleischmann RM | 2003 | J Rheumatol2003，30，： | 1 |
| 5 | Adalimumab, a fully human anti tumor necrosis factor-α monoclonal antibody, and concomitant standard antirheumatic therpy for the treatment of rheumatoid arthritis: results of STAR ( Safety Trial of Adalimumab in Rheumatoid Arthritis) 显示文摘 | Furst DE Schiff MH Fleischmann RM | 2003 | J Rheumatol2003，30，12： | 1 |
| 6 | Is there a need for new therapies for rheumatoid ar- thritis? 显示文摘 | Fleischmann RM | 2005 | J Rheumatol2005，，： | 1 |
| 7 | Longterm safety, efficacy,and radiographic outcome with etanercept treatment in pa- tients with early rheumatoid arthritis显示文摘 | Genovese MC Bathon JM Fleischmann RM | 2005 | J Rheum2005，32，7： | 1 |
| 8 | Clinical,functional and radiographic consequences of achieving stable low disease activity and remission with adalimumab plus methotrexate or methotrexate alone in early rheumatoid arthritis:26-week results from the randomised,controlled OPTIMA study显示文摘 | Kavanaugh A Fleischmann RM Emery P | | 0，，01： | 1 |
| 9 | Safety of extended treatment with anakinra in patients with rheumatoid arthritis显示文摘 | Fleischmann RM Tesser J Schiff MH | | 0，，08： | 1 |
| 10 | A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis 显示文摘 | Bathon JM Martin RW Fleischmann RM | 2000 | N Engl J Med2000，343，： | 1 |
| 11 | Is there a need for new therapies for rheumatoid arthritis 显示文摘 | Fleischmann RM | 2005 | J Rheumatol Suppl2005，73，： | 1 |
| 12 | A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis显示文摘 | Bathon JM Martin RW Fleischmann RM | 2000 | N Engl J Med2000，343，22： | 1 |
| 13 | Anakinra, a recombinant human interleukin-1 receptor antagonist (r- metHuIL-1ra),in patients with rheumatoid arthritis:A large, international, multicenter, placebo-controlled trial 显示文摘 | Fleischmann RM Schechtman J Bennett R | 2003 | Arthritis Rheum2003，48，4： | 1 |
| 14 | Pharmacokinetics and safety of golimumab, a fully human anti-TNF-alpha monoclonal antibody, in subjects with rheumatoid arthritis 显示文摘 | Zhou H Jang H Fleischmann RM | 2007 | J Clin Pharma*ol2007，47，3： | 1 |
| 15 | Safety of extended treatment with anakinra in patients with rheumatoid arthri- tis显示文摘 | Fleischmann RM Tesser J Schiff MH | 2006 | Ann Rheum Dis2006，65，8： | 1 |
| 16 | A comparision of etanercept and methotrexate in patients with early rheumatoid arthritis 显示文摘 | bathoin JM Martin RW Fleischmann RM | 2000 | N Eng J Med2000，343，22： | 1 |
| 17 | A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis显示文摘 | Bathon JM Martin RW Fleischmann RM | 2000 | N Engl J Med2000，343，： | 1 |
| 18 | Adalimumab, afully human anti tumor necrosis factor-alpha monoclonal antibody,and concomitant standard antirheumatic therapy for the treatment ofrheumatoid arthritis : results of STAR (Safety Trial of Adalimumabin Rheumatoid Arthritis) 显示文摘 | Furst DE Schiff MH Fleischmann RM | 2003 | J Rheumatol2003，30，12： | 1 |
| 19 | Anakinra, a recombinant human interleukin-1 receptor antagonist ( r-metHuIL-1ra), in patients with rheumatoid arthritis: a large, international, multicenter, placebo-controlled trial 显示文摘 | Fleischmann RM Schechtman J Bennett R | 2003 | Arthritis Rheum2003，48，： | 1 |
| 20 | Long-term(52-week)results of a phase 3,randomized,controlled trial of apremilast,an oral phosphodiesterase 4 inhibitor,in patients with psoriatic arthritis(PALACE 2)显示文摘 | Cutolo M Myerson GE Fleischmann RM | 2013 | Arthritis Rheum2013，65，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员